972
Views
13
CrossRef citations to date
0
Altmetric
Research Article

A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers

, , , , , , , & show all
Pages 190-198 | Received 15 Feb 2013, Accepted 29 Apr 2013, Published online: 07 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Azam Bolhassani, Niloofar Naderi & Sepehr Soleymani. (2017) Prospects and progress of Listeria-based cancer vaccines. Expert Opinion on Biological Therapy 17:11, pages 1389-1400.
Read now
Azam Bolhassani, Martin Muller, Farzin Roohvand, Fatemeh Motevalli, Elnaz Agi, Mehdi Shokri, Mahdieh Motamedi Rad & Sahar Hosseinzadeh. (2014) Whole recombinant Pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic Leishmania. Human Vaccines & Immunotherapeutics 10:12, pages 3499-3508.
Read now

Articles from other publishers (10)

Claudio Bandi, Jairo Alfonso Mendoza-Roldan, Domenico Otranto, Alessandro Alvaro, Viviane Noll Louzada-Flores, Massimo Pajoro, Ilaria Varotto-Boccazzi, Matteo Brilli, Alessandro Manenti, Emanuele Montomoli, Gianvincenzo Zuccotti & Sara Epis. (2023) Leishmania tarentolae: a vaccine platform to target dendritic cells and a surrogate pathogen for next generation vaccine research in leishmaniases and viral infections. Parasites & Vectors 16:1.
Crossref
Avinash Khadela, Yesha Shah, Priya Mistry, Kunjan Bodiwala & Avinash CB. (2023) Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects. Technology in Cancer Research & Treatment 22, pages 153303382211505.
Crossref
Prathap Somu & Subhankar Paul. 2021. Heat Shock Proteins in Human Diseases. Heat Shock Proteins in Human Diseases 1 29 .
Nastaran Ansari, Sima Rafati, Tahereh Taheri, Farzin Roohvand, Mohammad Farahmand, Zamaneh Hajikhezri, Abolfazl Keshavarz & Katayoun Samimi-Rad. (2019) A non-pathogenic Leishmania tarentolae vector based- HCV polytope DNA vaccine elicits potent and long lasting Th1 and CTL responses in BALB/c mice model. Molecular Immunology 111, pages 152-161.
Crossref
Alireza Milani, Marzieh Basirnejad & Azam Bolhassani. (2019) Heat-shock proteins in diagnosis and treatment: an overview of different biochemical and immunological functions. Immunotherapy 11:3, pages 215-239.
Crossref
Tahereh Taheri, Negar Seyed, Amir Mizbani & Sima Rafati. (2016) Leishmania-based expression systems. Applied Microbiology and Biotechnology 100:17, pages 7377-7385.
Crossref
Zeinab Shirbaghaee & Azam Bolhassani. (2016) Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems. Biopolymers 105:3, pages 113-132.
Crossref
Kimia Kardani, Azam Bolhassani & Sepideh Shahbazi. (2016) Prime-boost vaccine strategy against viral infections: Mechanisms and benefits. Vaccine 34:4, pages 413-423.
Crossref
Zeinab Shirbaghaee, Azam Bolhassani, Abbas Mirshafiey, Fatemeh Motevalli & Negar Zohrei. (2015) A Live Vector Expressing HPV16 L1 Generates an Adjuvant-Induced Antibody Response In-vivo. Iranian Journal of Cancer Prevention 8:6.
Crossref
Angamuthu Selvapandiyan, Ranadhir Dey, Sreenivas Gannavaram, Sumit Solanki, Poonam Salotra & Hira L. Nakhasi. (2014) Generation of growth arrested Leishmania amastigotes: A tool to develop live attenuated vaccine candidates against visceral leishmaniasis. Vaccine 32:31, pages 3895-3901.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.